Nanosphere, Inc.
4088 Commercial Avenue
Northbrook
Illinois
60062
United States
Tel: 847-400-9000
Fax: 847-400-9199
Website: http://www.nanosphere.us/
Email: info@nanosphere.us
169 articles about Nanosphere, Inc.
-
Between top-notch academic institutions, solid venture capital funding, expanding lab space and governmental support, Chicago is emerging as a true hotbed for biotech growth.
-
NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico
12/10/2018
Agreement will bring the patented NanoSphere Delivery System™ to an emerging $5 billion cannabis market
-
NanoSphere Develops New Product Eliminating Need to Smoke Cannabis
11/26/2018
NanoSphere Health Sciences Inc. is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles.
-
Evolve Formulas Transdermal NanoSerum™ CBD Met with Unprecedented Response across Colorado Market
11/7/2018
Industry-First Formulation Harnesses the Anti-Inflammatory Qualities of CBD and Antioxidant Power of Resveratrol for Maximum Wellness Benefits
-
NanoSphere Health Sciences and Vertical Companies™ Commence Production in California
10/10/2018
Award-Winning Evolve Formulas Transdermal NanoSerum™ To Hit Dispensary Shelves in the Golden State in Time for the Holidays
-
NanoSphere Health Sciences Expands to Indiana With Evolve Formulas NanoSerum™ Hemp
9/11/2018
Evolve Formulas Introduces New Hemp-Derived Product to Indiana Market, Launching in Mid-September
-
NanoSphere Health Sciences Partners with Delta 9 for Canadian Expansion
7/31/2018
Biotech Leader's Cannabis Division, Evolve Formulas, Prepares to Launch in Canadian Market
-
NanoSphere Health Sciences' Brand Evolve Formulas Expanding Rapidly Across Colorado and Beyond
7/11/2018
Next-Generation Cannabis Products Now Available in Over 200 Colorado Dispensaries, with Production Beginning in the California Market
-
CBD Naturals®' and NanoSphere™ Technologies Launch Strategic Partnership
6/13/2018
CBD Naturals® and NanoSphere™ Technologies have announced a strategic partnership designed to develop more nano-products.
-
Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team
6/7/2018
Dr. Michele Ross has joined the advisory board for NanoSphere Health Sciences, LLC
-
NanoSphere Health Sciences Retains Gravitas Securities and Grant Options
5/24/2018
Biotechnology leader NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF) has retained the services of Gravitas Securities Inc. ("Gravitas") to act as financial advisors to the company. NanoSphere also wishes to announce that it has granted 3,165,555 options to directors, officers and consultants of the company at a price of $0.65.
-
NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform
3/27/2018
Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery systems
-
NanoSphere Health Sciences Announces Name Change, CSE Listing and Conversion of %5.9M in Subscription Receipts
12/5/2017
NanoSphere's shares will commence trading tomorrow, December 5, 2017, under the symbol "NSHS".
-
Corazon and NanoSphere Announce Completion of $5.9M Financing and Merger
12/1/2017
Based upon the CSE's conditional listing approval, the Company will make its final submission for CSE listing in short order, and concurrently with its listing on the CSE will change its name to "NanoSphere Health Sciences Inc." and effect a de-listing from the TSX Venture Exchange.
-
Nanosphere Signs Binding Merger Agreement For 100% Acquisition By Corazon Gold Corp.
6/20/2017
-
Luminex Completes Acquisition Of Nanosphere
6/30/2016
-
Luminex Announces Commencement Of Tender Offer For All Outstanding Shares Of Nanosphere Common Stock
6/2/2016
-
Luminex Sweetens Nanosphere Bid to $102 Million
5/23/2016
-
Nanosphere Announces First Quarter Results
5/16/2016
-
Luminex Snaps Up Nanosphere for $56 Million
5/16/2016